Search

Search Constraints

You searched for: Author/Creator Giagounidis, Aristoteles

Search Results

1. A phase 3 randomized, placebo-controlled study assessing the efficacy and safety of epoetin-α in anemic patients with low-risk MDS. Issue 12 (December 2018)

2. Accurate quantification of chromosomal lesions via short tandem repeat analysis using minimal amounts of DNA. Issue 9 (9th June 2017)

3. Achievement of red blood cell transfusion independence in red blood cell transfusion-dependent patients with lower-risk non-del(5q) myelodysplastic syndromes correlates with serum erythropoietin levels. Issue 6 (11th May 2020)

4. Activity of the oral mitogen‐activated protein kinase kinase inhibitor trametinib in RAS‐mutant relapsed or refractory myeloid malignancies. Issue 12 (18th March 2016)

5. Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial. Issue 16 (December 2015)

6. Baseline and interim PET‐based outcome prediction in peripheral T‐cell lymphoma: A subgroup analysis of the PETAL trial. Issue 3 (18th February 2020)

8. Clonal architecture in patients with myelodysplastic syndromes and double or minor complex abnormalities: Detailed analysis of clonal composition, involved abnormalities, and prognostic significance. Issue 11 (24th September 2018)

9. Comparison Between 5-Azacytidine Treatment and Allogeneic Stem-Cell Transplantation in Elderly Patients With Advanced MDS According to Donor Availability (VidazaAllo Study). Issue 30 (20th October 2021)

10. CSNK1A1 mutations and gene expression analysis in myelodysplastic syndromes with del(5q). (18th June 2015)